0001246360-13-003266.txt : 20130610 0001246360-13-003266.hdr.sgml : 20130610 20130610164212 ACCESSION NUMBER: 0001246360-13-003266 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20130606 FILED AS OF DATE: 20130610 DATE AS OF CHANGE: 20130610 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: SYNAGEVA BIOPHARMA CORP CENTRAL INDEX KEY: 0000911326 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 561808663 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 128 SPRING STREET STREET 2: SUITE 520 CITY: LEXINGTON STATE: MA ZIP: 02421 BUSINESS PHONE: (781) 357-9900 MAIL ADDRESS: STREET 1: 128 SPRING STREET STREET 2: SUITE 520 CITY: LEXINGTON STATE: MA ZIP: 02421 FORMER COMPANY: FORMER CONFORMED NAME: TRIMERIS INC DATE OF NAME CHANGE: 19970516 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BOESS CARSTEN CENTRAL INDEX KEY: 0001277495 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-23155 FILM NUMBER: 13903886 MAIL ADDRESS: STREET 1: C/O ALEXION PHARMACEUTICALS STREET 2: 352 KNOTTER DR CITY: CHESHIRE STATE: CT ZIP: 06410 4 1 form.xml PRIMARY DOCUMENT X0306 4 2013-06-06 false 0000911326 SYNAGEVA BIOPHARMA CORP GEVA 0001277495 BOESS CARSTEN 33 HAYDEN AVE LEXINGTON MA 02421 false true false false SVP, Chief Financial Officer Stock Option (Right to Buy) 40.32 2013-06-06 4 A false 45000 0 A 2023-06-06 Common Stock 45000 45000 D 25% of the total number of shares subject to the option vest and become exercisable on June 6, 2014 and 1/36 of the remainder of the shares subject to the option shall vest and become exercisable monthly thereafter. /s/ Stephen F. Mahoney, Attorney-In-Fact 2013-06-10